Cargando…
Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761837/ https://www.ncbi.nlm.nih.gov/pubmed/35039647 http://dx.doi.org/10.1038/s41418-021-00909-6 |
| _version_ | 1784633621768830976 |
|---|---|
| author | Lin, Liangyu Wang, Ying Li, Qing Hu, Mingyuan Shi, Yufang |
| author_facet | Lin, Liangyu Wang, Ying Li, Qing Hu, Mingyuan Shi, Yufang |
| author_sort | Lin, Liangyu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8761837 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87618372022-01-18 Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence Lin, Liangyu Wang, Ying Li, Qing Hu, Mingyuan Shi, Yufang Cell Death Differ Editorial Nature Publishing Group UK 2022-01-17 2022-02 /pmc/articles/PMC8761837/ /pubmed/35039647 http://dx.doi.org/10.1038/s41418-021-00909-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Editorial Lin, Liangyu Wang, Ying Li, Qing Hu, Mingyuan Shi, Yufang Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence |
| title | Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence |
| title_full | Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence |
| title_fullStr | Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence |
| title_full_unstemmed | Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence |
| title_short | Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence |
| title_sort | novel sars-cov-2 therapeutic targets: rna proofreading complex and virus-induced senescence |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761837/ https://www.ncbi.nlm.nih.gov/pubmed/35039647 http://dx.doi.org/10.1038/s41418-021-00909-6 |
| work_keys_str_mv | AT linliangyu novelsarscov2therapeutictargetsrnaproofreadingcomplexandvirusinducedsenescence AT wangying novelsarscov2therapeutictargetsrnaproofreadingcomplexandvirusinducedsenescence AT liqing novelsarscov2therapeutictargetsrnaproofreadingcomplexandvirusinducedsenescence AT humingyuan novelsarscov2therapeutictargetsrnaproofreadingcomplexandvirusinducedsenescence AT shiyufang novelsarscov2therapeutictargetsrnaproofreadingcomplexandvirusinducedsenescence |